Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-12-01 Purchase |
2023-12-05 4:30 pm |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
1,800,000 | $10 | $18,000,000 | 12,168,489 (Indirect) |
View |
| 2022-11-04 Sale |
2022-11-08 5:51 pm |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
48,583 | $31.14 | $1,512,806 | 4,308,630 (Indirect) |
View |
| 2022-11-02 Sale |
2022-11-04 5:58 pm |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
78,220 | $33.95 | $2,655,330 | 4,386,850 (Indirect) |
View |
| 2022-10-31 Sale |
2022-11-02 9:02 pm |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
85,659 | $37.95 | $3,250,496 | 4,472,510 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-26 Option Award |
2024-06-28 07:45 am |
N/A 2034-06-25 |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
136,139 | $0 | 136,139 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 5:00 pm |
N/A 2033-06-14 |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
26,642 | $0 | 26,642 (Direct) |
View |
| 2022-11-04 Other |
2022-11-08 5:51 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
48,583 | $0 | 4,308,630 (Indirect) |
View |
| 2022-11-02 Other |
2022-11-04 5:58 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
78,220 | $0 | 4,386,850 (Indirect) |
View |
| 2022-10-31 Other |
2022-11-02 9:02 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
85,660 | $0 | 4,472,510 (Indirect) |
View |
| 2022-09-30 Option Award |
2022-10-04 8:10 pm |
N/A 2032-09-30 |
EQRx Inc. | EQRX | Yeshwant Krishna Director |
101,010 | $0 | 101,010 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-13 5:01 pm |
N/A 2032-06-08 |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
15,500 | $0 | 15,500 (Direct) |
View |
| 2021-06-21 Conversion |
2021-06-22 5:17 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
110,735,050 | $0 | 4,472,509 (Indirect) |
View |
Ownership |
2021-06-16 7:40 pm |
N/A N/A |
Verve Therapeutics Inc. | VERV | Yeshwant Krishna Director 10% Owner |
0 | $0 | 10,793,414 (Indirect) |
View |